Sjogren’s Syndrome

  • Robert I. Fox
  • Ichiro Saito

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson TC, III, RI Fox, DM Frisman, and FV Howell. 1983. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren’s syndrome using monoclonal antibodies. J Immunol 130: 203PubMedGoogle Scholar
  2. Akbar AN, Salmon M (1997) Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today 18: 72–76CrossRefPubMedGoogle Scholar
  3. Alexander EL, Provost TT (1983) Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 80: 386–391CrossRefPubMedGoogle Scholar
  4. Alexander E, Provost TT (1987) Sjögren’s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 123: 801–810CrossRefPubMedGoogle Scholar
  5. Alexander EL, Beall SS, Gordon B, Selnes LA, Yannakakis GD, Patronas N, Provost TT, McFarland HF (1988) Magnetic resonance imaging of cerebral lesions in patients with the Sjögren’s syndrome. Annals of Internal Medicine 108: 815–823PubMedGoogle Scholar
  6. Alpert S, Kang HI, Weissman I, Fox RI (1994) Expression of granzyme A in salivary gland biopsies from patients with primary Sjogren’s syndrome. Arthritis Rheum 37: 1046–1054PubMedGoogle Scholar
  7. Altmann D, Hogg J, Trowsdale J, Wilkinson D (1989) Cotransfection of ICAM-1 and HLA-DR reconstittutes human antigen-presenting cell function in mouse L cells. Nature 338: 512–514CrossRefPubMedGoogle Scholar
  8. Andoh Y, Shimura S, Sawai T, Sasaki H, Takishima T, Shirato K (1993) Morphometric analysis of secretory glands in Sjögren’s syndrome. Am Rev Respir Dis 148: 1358–1362PubMedGoogle Scholar
  9. Arnett F (1994) Histocompatibility typing in the rheumatic diseases: diagnostic and prognostic implications. Med Clin NA 20: 371–387Google Scholar
  10. Asherson RA, Fei HM, Staub HL, Khamashta MA, Hughes GRV, Fox RI (1992) Antiphospholipid antibodies and HLA associations in primary Sjögren’s syndrome. Ann Rheum Dis 51: 495–498PubMedGoogle Scholar
  11. Bachmann M, Grolz D, Bartsch H, Klein R, Troster H (1997) Analysis of expression of an alternative SS-B cDNA and localization of the encoded N and C terminal peptides. Bioch Bioph Acta 135: 53–63CrossRefGoogle Scholar
  12. Bacman SR, A Berra, L Sterin-Borda, and ES Borda. 1998. Human primary Sjogren’s syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 17: 1135CrossRefPubMedGoogle Scholar
  13. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN (1984) Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol 120: 332–337CrossRefPubMedGoogle Scholar
  14. Bielsa I, Herrero C, Collado A, Cobos A, Palou J, Mascaro JM (1994) Histopathologic findings in cutaneous lupus erythematosus. Arch Dermatol 130: 54–58CrossRefPubMedGoogle Scholar
  15. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ (1956) Sjögren’s syndrome: A clinical, pathological and serological study of 62 cases. Medicine (Baltimore) 44: 187–231Google Scholar
  16. Blomgren K, Kawashima S, Saido TC, Karlsson JO, Elmered A, Hagberg H (1995) Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxicischemia. Brain Res 684: 143–149CrossRefPubMedGoogle Scholar
  17. Boise L, Gonzalez M, Postema C, Ding L, Lindsten T, Rurka L, Mao X, Nunez G, Thompson C (1993) bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 599–608CrossRefGoogle Scholar
  18. Bolstad AI, HG Eiken, B Rosenlund, ME Alarcon-Riquelme, and R Jonsson. 2003. Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary SIncreased salivary gland tissue expression of Fas, jogren’s syndrome. Arthritis Rheum 48: 174CrossRefPubMedGoogle Scholar
  19. Boumba D, F Skopouli, and H Moutsopoulos. 1995. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren’s syndrome. Brit J Rheum 34: 326Google Scholar
  20. Breedveld FC (1997) Minocycline in rheumatoid arthritis [editorial; comment]. Arthritis Rheum 40: 794–796PubMedGoogle Scholar
  21. Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJ, Maini R (1992) The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 31: 735–742PubMedGoogle Scholar
  22. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EK (1994) Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren’s syndrome. J Immunol 152: 3675–3684PubMedGoogle Scholar
  23. Buyon JP (1996) Neonatal lupus. Curr Opin Rheumatol 8: 485–490PubMedGoogle Scholar
  24. Buyon JP, Tseng CE, Di Donato F, Rashbaum W, Morris A, Chan EK (1997) Cardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum 40: 655–660PubMedGoogle Scholar
  25. Campbell IL (1995) Neuropathogenic actions of cytokines assessed in transgenic mice. Int J Dev Neurosci 13: 275–284CrossRefPubMedGoogle Scholar
  26. Cannon MJ, Pisa P, Fox RI, Cooper NR (1990) Epstein-Barr virus induces aggressive lympho-proliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 85: 1333–1337PubMedGoogle Scholar
  27. Casciola-Rosen L, Anhalt G, Rosen A (1995) DNA dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 182: 1625–1634CrossRefPubMedGoogle Scholar
  28. Casiano CA, Martin SI, Green DR, Tan EM (1996a) Selective Cleavage of nuclear auto-antigens during CD95 (Fas/Apo-1) mediated T-cell apoptosis. J Exp Med 184: 765–70CrossRefPubMedGoogle Scholar
  29. Casiano CA, Tan EM (1996b) Recent developments in the understanding of antinuclear autoantibodies. Int Arch Allergy Immunol 111: 308–313PubMedGoogle Scholar
  30. Cho CS, Park SH, Min JK, Lee SH, Kim HY (1997) Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjogren’s syndrome. Korean J Intern Med 12: 176–181PubMedGoogle Scholar
  31. Cimaz R, A Casadei, C Rose, J Bartunkova, A Sediva, F Falcini, P Picco, M Taglietti, F Zulian, R Ten Cate, FR Sztajnbok, PV Voulgari, and AA Drosos. 2003. Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J PediatrGoogle Scholar
  32. Cyrus U, Bergeron L, Zho H, Li H, Yuan J (1996) Specific cleavage of Fodrin during Fas and tumor necrosis facor induced apoptosis is mediated by an ICE/CED-3 protease distinct from the poly (ADP)-ribose) polymerase protease. J Biol Chem 271: 31277–31282CrossRefPubMedGoogle Scholar
  33. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, Talal N (1995) SLE-like autoantibodies and Sjogren’s syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 155: 3205–3212PubMedGoogle Scholar
  34. Daniels T, Fox PC (1992a) Salivary and Oral Components of Sjogren’s Syndrome. Rheum Clinics NA 18: 571–583Google Scholar
  35. Daniels T, Fox PC (1992b) Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin North Am 18: 571–589PubMedGoogle Scholar
  36. Daniels T, Whitcher JP (1994) Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren’s syndrome. Arthritis Rheum 37: 869–877PubMedGoogle Scholar
  37. De Keyser F, Hoch SO, Takei M, Dang H, De Keyser H, Rokeach LA, Talal N (1992) Cross-reactivity of the B/B’ subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptides. Clin Immunol Immunopathol 62: 285–290CrossRefPubMedGoogle Scholar
  38. De Seze J, S Dubucquoi, AL Fauchais, T Matthias, D Devos, G Castelnovo, T Stojkovic, D Ferriby, E Hachulla, P Labauge, D Lefranc, PY Hatron, P Vermersch, and T Witte. 2003. alpha-Fodrin autoantibodies in the differential diagnosis of MS and Sjogren syndrome. Neurology 61: 268PubMedGoogle Scholar
  39. De Stefano R, S Manganelli, E Frati, E Selvi, A Azzi, K Zakrzewska, and R Marcolongo. 2003. No association between human parvovirus B19 infection and Sjogren’s syndrome. Ann Rheum Dis 62: 86CrossRefPubMedGoogle Scholar
  40. De Vita S 1996. Ductal Fas antigen and the pathobiology of Sjogren’s syndrome [editorial; comment]. Clin Exp Rheumatol 14: 231PubMedGoogle Scholar
  41. Diakowski W, Sikorski AF (1995) Interaction of brain spectrin (fodrin) with phospholipids. Biochemistry 34: 13252–13258CrossRefPubMedGoogle Scholar
  42. Edwards JC, LS Wilkinson, P Speight, and DA Isenberg. 1993. Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren’s syndrome and rheumatoid arthritis. Ann Rheum Dis 52: 806PubMedGoogle Scholar
  43. Ekstrom J (1989) Autonomic control of salivary secretion. Proc Finn Dent Soc 85: 323–331PubMedGoogle Scholar
  44. Esch TR, MV Jonsson, VA Levanos, JD Poveromo, and BC Sorkin. 2000. Leukocytes infiltrating the submandibular glands of NOD mice express E-cadherin. J Autoimmun 15: 387CrossRefPubMedGoogle Scholar
  45. Ferraccioli GF, De Vita S, Casatta L, Damato R, Pegoraro I, Bartoli E (1996) Autoimmune connective tissue disease, chronic polyarthritides and B cell expansion: risks and perspectives with immunosuppressive drugs. Clin Exp Rheumatol 14Suppl 14: S71–80PubMedGoogle Scholar
  46. Fern C, La Civita L, Longombardo G, Zignego AL, Pasero G (1998) Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 7: 275–279CrossRefPubMedGoogle Scholar
  47. Fishleder A, Tubbs R, Hesse B, Levin H (1987) Immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 316: 1118–1121PubMedGoogle Scholar
  48. Flemmig TF, Weinacht S, Rudiger S, Rumetsch M, Jung A, Klaiber B (1996) Adjunctive controlled topical application of tetracycline HCl in the treatment of localized persistent or recurrent periodontitis. Effects on clinical parameters and elastase-alphal-proteinase inhibitor in gingival crevicular fluid. J Clin Periodontol 23: 914–921PubMedGoogle Scholar
  49. Fox RI, Adamson III TC, Fong S, Robinson CA, Morgan EL, Robb JA, Howell FV (1983) Lymphocyte phenotype and function of pseudolymphomas associated with Sjögren’s syndrome. J Clin Invest 72: 52–62PubMedGoogle Scholar
  50. Fox RI, Carson DA, Chen P, Fong S (1986a) Characterization of a cross reactive idiotype in Sjögren’s syndrome. Scand J Rheumatol 561: 83–88Google Scholar
  51. Fox RI, Chen PP, Carson DA, Fong S (1986b) Expression of a cross reactive idiotype on rheumatoid factor in patients with Sjögren’s syndrome. J Immunol 136: 477–483PubMedGoogle Scholar
  52. Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV (1988) Treatment of primary Sjögren’s syndrome with hydroxychloroquine. Amer J Med 85: 62–67CrossRefPubMedGoogle Scholar
  53. Fox RI, PP Chen, DA Carson, and S Fong (1986c) Expression of a cross reactive idiotype on rheumatoid factor in patients with Sjögren’s syndrome. J Immunol 136: 477PubMedGoogle Scholar
  54. Fox RI, Wilson C (1993) Sjögren’s syndrome: The association of interstitial nephritis and keratoconjunctivitis. Diseases affecting the eye and the kidney 266–276Google Scholar
  55. Fox RI, Kang HI, Ando D, Abrams J, Pisa E (1994a) Cytokine mRNA expression in salivary gland biopsies of Sjogren’s syndrome. J Immunol 152: 5532–5539PubMedGoogle Scholar
  56. Fox RI (1994) Classification Criteria for Sjogren’s syndrome. Rheumatic Disease Clinics of North America: Current Controversies in Rheumatology 20: 391–407Google Scholar
  57. Fox R, Kang H, Pisa E (1994) Cytokine transcription in salivary gland biopsies of Sjögren’s syndrome. J Immunol 151: 132–142Google Scholar
  58. Fox RI, Saito I (1994) Criteria for diagnosis of Sjogren’s syndrome. Rheum Dis Clin North Am 20: 391–407PubMedGoogle Scholar
  59. Fox RI, HI Kang, D Ando, J Abrams, and E Pisa (1994) Cytokine mRNA expression in salivary gland biopsies of Sjogren’s syndrome. J Immunol 152: 5532PubMedGoogle Scholar
  60. Fox RI (1995) Sjogren’s syndrome. Curr Opin Rheumatol 7: 409–416PubMedGoogle Scholar
  61. Fox RI (1996) Clinical features, pathogenesis, and treatment of Sjogren’s syndrome. Curr Opin Rheumatol 8: 438–445PubMedGoogle Scholar
  62. Fox RI, Dixon R, Guarrasi V, Krubel S (1996) Treatment of primary Sjogren’s syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5Suppl 1: S31–36PubMedGoogle Scholar
  63. Fox R (1997) Sjogren’s syndrome: Progress and controversies. Med Clin NA 17: 441–534Google Scholar
  64. Fox RI (1998) Sjogren’s syndrome. Pathogenesis and new approaches to therapy. Adv Exp Med Biol 438: 891–902PubMedGoogle Scholar
  65. Fox RI, J Tornwall, T Maruyama, and M Stern (1998) Evolving concepts of diagnosis, pathogenesis, and therapy of Sjogren’s syndrome. Curr Opin Rheumatol 10: 446PubMedGoogle Scholar
  66. Fox RI, J Tornwall, and P Michelson (1999) Current issues in the diagnosis and treatment of Sjogren’s syndrome. Curr Opin Rheumatol 11: 364CrossRefPubMedGoogle Scholar
  67. Fox RI (2000) Sjogren’s syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs 9: 2007–2016CrossRefPubMedGoogle Scholar
  68. Fox RI, and M Stern (2002) Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl: 3Google Scholar
  69. Fredriksen C, AC Johannessen, and R Jonsson. 1995. T-cell receptor V-gene usage in Sjogren’s syndrome. Adv Exp Med Biol 371B: 1203PubMedGoogle Scholar
  70. Freemont AJ, and CJP Jones. 1983. Endothelial specialization of salivary gland vessels for accelerated lymphocyte transfer in Sjögren’s syndrome. J Rheum. 10: 801PubMedGoogle Scholar
  71. Freimark B, Fox RI (1987) Detection of Clonally Detected T and B Cells in Salivary Gland Biopsies of Sjogren’s sjogren lacking myoepithelial islands. N E J Med 317: 1158Google Scholar
  72. Friedlaender MH, Fox RI (1998) Punctal occlusion for the treatment of dry eye. Adv Exp Med Biol 438: 1017–1020PubMedGoogle Scholar
  73. Gellrich S, S Rutz, A Borkowski, S Golembowski, E Gromnica-Ihle, W Sterry, and S Jahn. 1999. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjogren’s syndrome. Arthritis Rheum 42: 240CrossRefPubMedGoogle Scholar
  74. Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, Mancia D (1994) Peripheral neuropathy associated with primary Sjogren’s syndrome. J Neurol Neurosurg Psychiatry 57: 983–986PubMedGoogle Scholar
  75. Grant IA, Hunder GG, Homburger HA, Dyck PJ (1997) Peripheral neuropathy associated with sicca complex. Neurology 48: 855–862PubMedGoogle Scholar
  76. Greenwalt R, Golub L, Lavietas B, Ramamurthy N, Gruber B, Laskin R, McNamera T (1994) Tetracyclines inhibit human collagenase in vivo and in vitro. J Rheum 14: 28–32Google Scholar
  77. Griffiths DJ, Venables PJ, Weiss RA, Boyd MT (1997) A novel exogenous retrovirus sequence identified in humans. J Virol 71: 2866–2872PubMedGoogle Scholar
  78. Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, Lancien G, Veillard E, Pawlotsky Y, Perdriger A (1998) Primary Sjogren’s syndrome: role of the HLA-DRB1* 0301-* 1501 heterozygotes. J Rheumatol 25: 900–905PubMedGoogle Scholar
  79. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC (1992) Lymphocytic sialadenitis of Sj ögren’s syndrome associated with chronic hepatitis C virus liver disease. Lancet 8: 321–323Google Scholar
  80. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276: 604–607CrossRefPubMedGoogle Scholar
  81. Harley JB, Sestalk AL, Willia LG, Fu SM, Hansen JA, Reichlin M (1989) A model for disease heterogenecity in systemic lupus erythematosus. Arthritis Rheum 32: 826–36PubMedGoogle Scholar
  82. Harper JI (1982) Subacute cutaneous lupus erythematosus (SCLE): a distinct subset of LE Clin Exp Dermatol 7: 209–212PubMedGoogle Scholar
  83. Hayashi Y, Haneji N, Hamano H (1994) Pathogenesis of Sjogren’s syndrome-like autoimmune lesions in MRL/lpr mice. Pathol Int 44: 559–568PubMedGoogle Scholar
  84. Hebbar M, Hebbar-Savean K, Hachulla E, Brouillard M, Hatron PY, Devulder B (1995) Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjogren’s syndrome. Ann Med Interne 146: 235–238Google Scholar
  85. Hershberg R, Framson P, Cho D, Lee L, Kovats S, Beitz J, Blum J, Nepom G (1997) Epithelial Cells use two distinct pathways for HLA Class II antigen processing. J Clin Inv 100: 204–215Google Scholar
  86. Hicks SJ, Carrington SD, Kaswan RL, Stern ME, Corfield AP (1995) Secreted and membrane bound ocular mucins from normal and dry eye dogs. Biochem Soc Trans 23: 537SPubMedGoogle Scholar
  87. Horsfall AC, Li JM, Maini RN (1996) Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block. J Autoimmun 9: 561–568CrossRefPubMedGoogle Scholar
  88. Hu Y, Purushotham KR, Wang P, Dawson R, Jr, Humphreys-Beher MG (1994) Down-regulation of beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 266: G433–443PubMedGoogle Scholar
  89. Hulkkonen J, J Vilpo, L Vilpo, T Koski, and M Hurme (2000) Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85: 600PubMedGoogle Scholar
  90. Humphreys-Beher MG (1996) Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 10: 73–75PubMedGoogle Scholar
  91. Humphreys-Beher MG, and AB Peck (1999) New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 44Suppl 1: S21CrossRefPubMedGoogle Scholar
  92. Hyde H, Borthwick NJ, Janossy G, Salmon M, Akbar AN (1997) Upregulation of intracellular glutathione by fibroblast-derived factor(s): enhanced survival of activated T cells in the presence of low Bcl-2. Blood 89: 2453–2460PubMedGoogle Scholar
  93. Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK (1995) Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci 36: 1818–1827PubMedGoogle Scholar
  94. Inatomi T, Spurr-Michaud S, Tisdale AS, Zhan Q, Feldman ST, Gipson IK (1996) Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci 37: 1684–1692PubMedGoogle Scholar
  95. Jabs DA, Burns WH, Prendergast RA (1996) Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci 37: 246–250PubMedGoogle Scholar
  96. Janz DM, van der Kraak G (1997) Suppression of apoptosis by gonadotropin, 17beta-estradiol, and epidermal growth factor in rainbow trout preovulatory ovarian follicles. Gen Comp Endocrinol 105: 186–193CrossRefPubMedGoogle Scholar
  97. Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G (1998) DRB1*15 and DRB1 *03 extended haplotype interaction in primary Sjogren’s syndrome genetic susceptibility. Clin Exp Rheumatol 16: 725–728PubMedGoogle Scholar
  98. Johnson EO, Skopouli FN, Moutsopoulos HM (2000) Neuroendocrine manifestations in Sjogren’s Syndrome [In Process Citation]. Rheum Dis Clin North Am 26: 927–949PubMedGoogle Scholar
  99. Jonsson R, TP Gordon, and YT Konttinen. 2003. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren’s syndrome. Curr Rheumatol Rep 5: 311PubMedGoogle Scholar
  100. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, Bologna C, Bourrat L, Combe B, Blanc F, Sany J (1996) Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 39: 1166–1171PubMedGoogle Scholar
  101. Jubert C, Cosnes A, Clerici T, Gaulard P, Andre P, Revuz J, Bagot M (1993) Sjogren’s syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum 36: 133–134PubMedGoogle Scholar
  102. Kang HI, Fei H, Fox RI (1991) Comparison of genetic factors in Chinese, Japanese and Caucasoid patients with Sjöjren’s syndrome. Arthritis & Rheum 34: S41 (supplement)Google Scholar
  103. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89: 888–892PubMedGoogle Scholar
  104. Katayama I, Koyano T, Nishioka K (1994) Prevalence of eyelid dermatitis in primary Sjogren’s syndrome. Int J Dermatol 33: 421–424PubMedGoogle Scholar
  105. Kizu Y, H Sakurai, S Katagiri, N Shinozaki, M Ono, K Tsubota, and J Saito. 1996. Immuno-histological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands. J Clin Pathol 49: 728PubMedGoogle Scholar
  106. Koike K, Monya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K, Matsura Y, Miyamaura T (1997) Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Nat Acad Sci 94: 233–236CrossRefPubMedGoogle Scholar
  107. Kong L, Ogawa N, Nakabayashi T, Liu GT, D’Souza E, McGuff HS, Guerrero D, Talal N, Dang H (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren’s syndrome. Arthritis Rheum 40: 87–97PubMedGoogle Scholar
  108. Konishi M, Ohosone Y, Matsumura M, Oyamada Y, Yamaguchi K, Kawahara Y, Mimon T, Ikeda Y (1997) Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms. Intern Med 36: 62–67PubMedGoogle Scholar
  109. Konttinen YT, Sorsa T, Hukkanen M, Segerberg M, a et. (1992) Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjögren’s syndrome. J Rheumatol 19: 30–37PubMedGoogle Scholar
  110. Konttinen YT, Tornwall J, Kemppinen P, Uusitalo H, Sorsa T, Hukkanen M, Polak JM (1996) Neutral endopeptidase (EC 3.4.24.11) in labial salivary glands in healthy controls and in patients with Sjogren’s syndrome. Ann Rheum Dis 55: 513–519PubMedGoogle Scholar
  111. Konttinen YT, Halinen S, R Hanemaaijer, T Sorsa, J Hietanen, A Ceponis, J W Xu, R Manthorpe, J Whittington, A Larsson, T Salo, L Kjeldsen, U H Stenman, and A Z Eisen (1998) Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjogren’s syndrome. Matrix Biol 17: 335CrossRefPubMedGoogle Scholar
  112. Koski H, A Janin, MG Humphreys-Beher, T Sorsa, M Malmstrom, and YT Konttinen (2001) Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren’s syndrome. Clin Exp Rheumatol 19: 131PubMedGoogle Scholar
  113. Koski H, YT Konttinen, J Hietanen, T Tervo, and M Malmstrom (1997) Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjogren’s syndrome. J Rheumatol 24: 1930PubMedGoogle Scholar
  114. Kroemer G (1997) The proto-oncogene bcl-2 and its role in regulating apoptosis. Nature Medicine 3: 614–620CrossRefPubMedGoogle Scholar
  115. Kyle R et al. (1971) Benign hyperglobuliemic purpura of Waldenstrom. Medicine (Baltimore) 50: 113–123Google Scholar
  116. Lee LA, Pickrell MB, Reichlin M (1996) Development of complete heart block in an adult patient with Sjogren’s syndrome and anti-Ro/SS-A autoantibodies. Arthritis Rheum 39: 1427–1429PubMedGoogle Scholar
  117. Lemp MA (1987) Tear film: new concepts and implications for the management of the dry eye. Trans New Orleans Acad Ophthalmol 35: 53–64PubMedGoogle Scholar
  118. Li DQ, Tseng SC (1995) Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 163: 61–79CrossRefPubMedGoogle Scholar
  119. Li JM, Fan WS, Horsfall AC, Anderson AC, Rigby S, Larsson E, Venables PJ (1996) The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 104: 388–393PubMedGoogle Scholar
  120. Liu Z, M Carvajal, CA Carothers Carraway, KL Carraway, and SC Pflugfelder. 2000. Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca. Am J Ophthalmol 129: 472CrossRefPubMedGoogle Scholar
  121. Lu G, Beuerman RW, Zhao S, Sun G, Nguyen DH, Ma S, Kline DG (1997) Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human neuroma fibroblasts. Neurochem Int 30: 401–410CrossRefPubMedGoogle Scholar
  122. Lutz HU, Pfister M, Hornig R (1996) Tissue homeostatic role of naturally occurring anti-band 3 antibodies. Cell Mol Biol (Noisy-le-grand) 42: 995–1005Google Scholar
  123. Magro CM, Crowson AN (1999) The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. Am J Dermatopathol 21: 129–137CrossRefPubMedGoogle Scholar
  124. Main C, Blennerhassett P, Collins SM (1993) Human recombinant interleukin 1 beta suppresses acetylcholine release from rat myenteric plexus. Gastroenterology 104: 1648–1654.PubMedGoogle Scholar
  125. Manganelli P, and P Fietta 2003 Apoptosis and Sjogren syndrome. Semin Arthritis Rheum 33:49CrossRefPubMedGoogle Scholar
  126. Manger K, Kalden JR, Manger B (1996) Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 35: 669–675PubMedGoogle Scholar
  127. Mariette X, Cazals-Hatem D, Agbalika F, Selimi F, Brunet M, Morinet F, Gluckman E (1996) Absence of cytomegalovirus and Epstein-Barr virus expression in labial salivary glands of patients with chronic graft-versus-host disease. Bone Marrow Transplant 17: 607–610PubMedGoogle Scholar
  128. Marriette X 2003. Lack of benefit of Infliximab in Sjogren’s Syndrome. Arth Rheum abstract S19Google Scholar
  129. Martin SJ, O’Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270: 6425–6428PubMedGoogle Scholar
  130. Matsumura R, M Kagami, H Tomioka, E Tanabe, T Sugiyama, M Sueishi, A Nakajima, M Azuma, and K Okumura. 1996. Expression of ductal Fas antigen in sialoadenitis of Sjogren’s syndrome [see comments]. Clin Exp Rheumatol 14: 309PubMedGoogle Scholar
  131. McCauliffe DP, Faircloth E, Wang L, Hashimoto T, Hoshino Y, Nishikawa T (1996) Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjogren’s syndrome and subacute cutaneous lupus erythematosus. Arch Dermatol 132: 528–531CrossRefPubMedGoogle Scholar
  132. Merke PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126: 866–873PubMedGoogle Scholar
  133. Merne ME, Syrjanen SM (1996) Detection of Epstein-Barr virus in salivary gland specimens from Sjogren’s syndrome patients. Laryngoscope 106: 1534–1539CrossRefPubMedGoogle Scholar
  134. Miyagawa S, Iida T, Fukumoto T, Matsunaga T, Yoshioka A, Shirai T (1995) Anti-Ro/SSA-as-sociated annular erythema in childhood. Br J Dermatol 133: 779–782PubMedGoogle Scholar
  135. Mody GM, Cassim B (1998) Rheumatologic manifestations of gastrointestinal disorders. Curr Opin Rheumatol 10: 67–72PubMedGoogle Scholar
  136. Mountz JD, Wu J, Cheng J, Zhou T (1994) Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37: 1415–1420PubMedGoogle Scholar
  137. Murata H, Y Kita, A Sakamoto, I Matsumoto, R Matsumura, T Sugiyama, M Sueishi, K Takabayashi, I Iwamoto, Y Saitoh, and et al. (1995) Limited TCR repertoire of infiltrating T cells in the kidneys of Sjogren’s syndrome patients with interstitial nephritis. J Immunol 155: 4084PubMedGoogle Scholar
  138. Namekawa T, K Kuroda, T Kato, K Yamamoto, H Murata, T Sakamaki, K Nishioka, I Iwamoto, Y Saitoh, and T Sumida (1995) Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjogren’s syndrome. J Rheumatol 22: 2092PubMedGoogle Scholar
  139. Navarr M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G, Lopez-Soto A, Ordinas A, Ingelmo M (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6: 521–526PubMedGoogle Scholar
  140. Nelson JD (1994) Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 34: 37PubMedGoogle Scholar
  141. Newkirk MM, Shiroky JB, Johnson N, Danoff D, Isenberg DA, Shustik C, Pearson GR (1996) Rheumatic disease patients, prone to Sjogren’s syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2. Br J Rheumatol 35:1075–1081CrossRefPubMedGoogle Scholar
  142. Nikitakis NG, H Rivera, C Lariccia, JC Papadimitriou, and JJ Sauk (2003) Primary sjogren syndrome in childhood: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 42PubMedGoogle Scholar
  143. Nozawa K, Kayagaki N, Tokano Y, Yagita H, Okumura K, Hasimoto H (1997) Solube Fas (Apo-1, CD95) and Soluble Fas ligandin rheumatic diseases. Arth Rheum 40: 1126–1129Google Scholar
  144. O’Donnell B, Black AK (1995) Urticarial vasculitis. Int Angiol 14: 166–174PubMedGoogle Scholar
  145. Ochs RL, Stein TW jr, Chan EK, Ruutu M, Tan EM (1996) cDNA cloning and characterization of a novel nucleolar protein. Mol Biol Cell 7: 1015–1024PubMedGoogle Scholar
  146. Ogawa N, Dang H, Kong L, Anaya J, Liu G, Talal N (1996) Lymphocyte apoptosis and apoptosis-associated gene expression in Sj ogren’s syndrome. Arth Rheum 39: 1875–1886Google Scholar
  147. Ohlsson M, K Skarstein, AI Bolstad, AC Johannessen, and R Jonsson (2001) Fas-induced apoptosis is a rare event in Sjogren’s syndrome. Lab Invest 81: 95PubMedGoogle Scholar
  148. Ohyama Y, S Nakamura, G Matsuzaki, M Shinohara, A Hiroki, M Oka, and K Nomoto (1995) T-cell receptor V alpha and V beta gene use by infiltrating T cells in labial glands of patients with Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 730PubMedGoogle Scholar
  149. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Fujimura T, Yamada A, Itoh K, Nomoto K (1996) Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren’s syndrome. Arthritis Rheum 39: 1376–1384PubMedGoogle Scholar
  150. Pablos JL, Cogolludo V, Pinedo F, Carreira PE (1993) Subcutaneous nodular amyloidosis in Sjögren’s syndrome. Scand J Rheumatol 22: 250–251PubMedGoogle Scholar
  151. Perez B, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D (1995) Autoimmune thyroid disease in primary Sjogren’s syndrome. Am J Med 99: 480–484CrossRefPubMedGoogle Scholar
  152. Pflugfelder S, Crouse C, Monroy D, Yen M, Rowe M, Atherton S (1993) EBV and the lacrimal gland pathology of Sjogrens syndrome. Am J Path 143: 49–64PubMedGoogle Scholar
  153. Pflugfelder SC, A Solomon, and ME Stern. 2000. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 19: 644CrossRefPubMedGoogle Scholar
  154. Pflugfelder SC, D Jones, Z Ji, A Afonso, and D Monroy (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca. Curr Eye Res 19: 201.CrossRefPubMedGoogle Scholar
  155. Pflugfelder SC, Tseng SC, Yoshino K, Monroy D, Felix C, Reis BL (1997) Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 104: 223–235PubMedGoogle Scholar
  156. Piepenhagen PA, Peters LL, Lux SE, Nelson WJ (1995) Differential expression of Na(+)-K(+)-ATPase, ankyrin, fodrin, and E-cadherin along the kidney nephron. Am J Physiol 269: C1417–1432PubMedGoogle Scholar
  157. Pisa EK, Pisa P, Kang HI, Fox RI (1991) High frequence of t(14;18) translocation in salivary gland lymphomas from Sjögren’s syndrome patients. J Exp Med 174: 1245–1250CrossRefPubMedGoogle Scholar
  158. Provost TT, Watson R, Simmons-O’Brien E (1997) Anti-Ro(SS-A) antibody positive Sjogren’s/ lupus erythematosus overlap syndrome. Lupus 6: 105–111PubMedGoogle Scholar
  159. Ramos-Casals M, Cervera R, Yague J, Garcia-Carrasco M, Trejo O, Jimenez S, Morla RM, Font J, Ingelmo M (1998) Cryoglobulinemia in primary Sjogren’s syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 28: 200–205CrossRefPubMedGoogle Scholar
  160. Reveille J, Wilson R, Provost T, Bias W, Arnett F (1984) Primary Sjögren’s syndrome and other autoimmune diseases in families. Ann Intern Med 101: 748PubMedGoogle Scholar
  161. Ricci RM, Meffert JJ, McCollough ML (1998) Primary anetoderma. Cutis 62: 101–103PubMedGoogle Scholar
  162. Rigby S, Cooke S, Weeransing D he, Venables P (1996) Absence of HTLV-1 tax in Sjogren’s syndrome. Arth Rheum 39: 1609–1610Google Scholar
  163. Robinson C, Yamciuka S, Alford C, Cooper C, Pichardo E, Shah N, Peck M, Humphrey-Beher M (1997) Elevated levels of cysteine protease activity in saliva and salivary glands of NOD mouse model for Sjogren’s syndrome. Proc Nat Acad Sci 94: 5767–5771CrossRefPubMedGoogle Scholar
  164. Robinson CP, Yamamoto H, Peck AB, Humphreys-Beher MG (1996) Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 79: 50–59CrossRefPubMedGoogle Scholar
  165. Roncin S, L Guillevin, M Beaugrand, S Vallet, YL Pennec, J Colin, and P Youinou. 1995. Identification of the T cell antigen receptor V beta gene products in labial salivary glands from patients with primary Sjogren’s syndrome. Ann Med Interne (Paris) 146: 226Google Scholar
  166. Ruzicka T, Faes J, Bergner T, Peter RU, Braun-Falco O (1991) Annular erythema associated with Sjogren’s syndrome: a variant of systemic lupus erythematosus [see comments]. J Am Acad Dermatol 25: 557–560PubMedGoogle Scholar
  167. Saari H, Halinen S, Ganlov K, Sorsa T, Konttinen YT (1997) Salivary mucous glycoprotein MG1 in Sjogren’s syndrome. Clin Chim Acta 259: 83–96CrossRefPubMedGoogle Scholar
  168. Sais G, Admella C, Fantova MJ, Montero JC (1998) Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjogren’s syndrome. Br J Dermatol 139: 1073–1076CrossRefPubMedGoogle Scholar
  169. Saito I, Servenius B, Compton T, Fox RI (1989) Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome. J Exp Med 169: 2191–2198CrossRefPubMedGoogle Scholar
  170. Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107: 631–639CrossRefPubMedGoogle Scholar
  171. Scofield RH, KM Kaufman, U Baber, JA James, JB Harley, and BT Kurien 1999. Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum 42: 1017CrossRefPubMedGoogle Scholar
  172. Sestak AL, Shaver TS, Moser KL, Neas BR, Harley JB (1999) Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol 26: 1495–1499PubMedGoogle Scholar
  173. Shattles WG, Brookes SM, Venables PJ, Clark DA, Maini RN (1992) Expression of anitgen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren’s syndrome. Clin Exp Immunol 89: 46–51PubMedGoogle Scholar
  174. Singer DR, Venning MC, Lockwood CM, Pusey CD (1986) Cryoglobulinaemia: clinical features and response to treatment [published erratum appears in Ann Med Interne (Paris) 1986; 137(5): 436]. Ann Med Interne 137: 251–253Google Scholar
  175. Skopouli, FN, and HM Moutsopoulos (1995) Cytokines in Sjogren’s syndrome. Ann Med Interne (Paris) 146: 219Google Scholar
  176. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM (1996) Methotrexate in primary Sjogren’s syndrome. Clin Exp Rheumatol 14: 555–558PubMedGoogle Scholar
  177. Slomiany BL, Murty VL, Piotrowski J, Slomiany A (1996) Salivary mucins in oral mucosal defense. Gen Pharmacol 27: 761–771PubMedGoogle Scholar
  178. Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kalden JR, Lahita R, Maini RN, Reeves W, Reichlin M, Rothfield N, Takasaki Y, van Venrooij WJ, Tan EM (1997) Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis Rheum 40: 413–418PubMedGoogle Scholar
  179. Soliven B, Wang N (1995) Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells. J Neurochem 64: 883–894PubMedGoogle Scholar
  180. Spezialetti R, Bluestein HG, Peter JB, Alexander EL (1993) Neuropsychiatric disease in Sjogren’s syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 95: 153–160CrossRefPubMedGoogle Scholar
  181. Stem ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998a) A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 438: 643–651PubMedGoogle Scholar
  182. Stem ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998b) The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17: 584–589PubMedGoogle Scholar
  183. Stern ME, J Gao, TA Schwalb, M Ngo, DD Tieu, CC Chan, BL Reis, SM Whitcup, D Thompson, and JA Smith. 2002. Conjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eye. Invest Ophthalmol Vis Sci 43: 2609PubMedGoogle Scholar
  184. Stemberg EM 2001. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169: 429CrossRefPubMedGoogle Scholar
  185. Sullivan DA, Wickham LA, Rocha EM, Krenzer KL, Sullivan BD, Steagall R, Cermak JM, Dana MR, Ullman MD, Sato EH, Gao J, Rocha FJ, Ono M, Silveira LA, Lambert RW, Kelleher RS, Tolls DB, Toda I (1999) Androgens and dry eye in Sjogren’s syndrome. Ann NY Acad Sci 876: 312–324PubMedGoogle Scholar
  186. Sumida T, Yonaha F, Maeda T, Kita Y, Yoshida S (1994) Expression of sequences homologous to HTLV-1 Tax gene in the labial salivary glands of Japanese patients with Sjogren’s syndrome. Arth Rheum 37: 545–550Google Scholar
  187. Suzuki M, Nagata S, Hiramatsu K, Takagi I, Ito H, Kitao S, Ito M, Ohta N, Baba S (1996) Elevated levels of soluble Fc epsilon RII/CD23 and antibodies to Epstein-Barr virus in patients with Sjogren’s syndrome. Acta Otolaryngol Suppl (Stockh) 525: 108–112PubMedGoogle Scholar
  188. Tapinos NI, M Polihronis, AG Tzioufas, and HM Moutsopoulos (1999) Sjogren’s syndrome. Autoimmune epithelitis. Adv Exp Med Biol 455: 127PubMedGoogle Scholar
  189. Tapinos NI, Polihronis M, Moutsopoulos HM (1999) Lymphoma development in Sjogren’s syndrome: novel p53 mutations. Arthritis Rheum 42: 1466–1472CrossRefPubMedGoogle Scholar
  190. Theofilopoulos AN (1995) The basis of autoimmunity: Part I Mechanisms of aberrant self-recognition. Immunol Today 16: 90–98CrossRefPubMedGoogle Scholar
  191. Tseng CE, Chan EK, Miranda E, Gross M, Di Donato F, Buyon JP (1997) The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex. Arthritis Rheum 40: 936–944PubMedGoogle Scholar
  192. Tsutsumi A, K Sasaki, N Wakamiya, K Ichikawa, T Atsumi, K Ohtani, Y Suzuki, T Koike, and T Sumida. 2001. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren’s syndrome. Genes Immun 2: 99CrossRefPubMedGoogle Scholar
  193. Vazquez J, Fernandez-Shaw C, Marina A, Haas C, Cacabelos R, Valdivieso F (1996) Anti-bodies to human brain spectrin in Alzheimer’s disease. J Neuroimmunol 68: 39–44CrossRefPubMedGoogle Scholar
  194. Vissink A, Spijkervet FK, Van Nieuw Amerongen A (1996) Aging and saliva: a review of the literature. Spec Care Dentist 16: 95–103PubMedGoogle Scholar
  195. Vitali C, Moutsopoulos HM, Bombardieri S (1994) The European Community Study Group on diagnostic criteria for Sjogren’s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s syndrome. Ann Rheum Dis 53: 637–647PubMedGoogle Scholar
  196. Vitali C, Bombardieri S (1997) The Europian classification criteria for Sjogren’s syndrome (SS): proposal for modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROCS) curve of the criteria performance. J Rheum 24(supplement): S18Google Scholar
  197. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, 3rd, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159: 174–181CrossRefPubMedGoogle Scholar
  198. Wagenmann A, Kato T, Yamamoto K, Nishoka K, Burmester G, Hiepe F (1996) Anti-52 kd SSa autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J Rheum 23: 462–468PubMedGoogle Scholar
  199. Walcott B, Claros N (1998) Age related decrease in innervation density of the lacrimal gland in mouse models of Sjogren’s syndrome. Adv Exp Med Biol 438: 917–923PubMedGoogle Scholar
  200. Watanabe H, Fabricant M, Tisdale AS, Spurr-Michaud SJ, Lindberg K, Gipson IK (1995) Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface. Invest Ophthalmol Vis Sci 36: 337–344PubMedGoogle Scholar
  201. Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K (1997) Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J Am Acad Dermatol 36: 214–218PubMedGoogle Scholar
  202. Wen S, Shimizu N, Yoshiyama H, Mizugaki Y, Shinozaki F, Takada K (1996) Association of Epstein-Barr virus (EBV) with Sjogren’s syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 149: 1511–1517PubMedGoogle Scholar
  203. Whitcher JP, TE Daniels, and MD Sherman (1994) Correlation of labial salivary gland biopsies with ocular and oral findings in patients with Sjogren’s syndrome. Adv Exp Med Biol 350: 667PubMedGoogle Scholar
  204. Whitcher JP jr, Gritz DC, Daniels TE (1998) The dry eye: a diagnostic dilemma. Int Ophthalmol Clin 38: 23–37PubMedGoogle Scholar
  205. Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clin North Am 22: 133–154CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Robert I. Fox
  • Ichiro Saito

There are no affiliations available

Personalised recommendations